help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by JARJOUR, N. N.
Right arrow Articles by ENHORNING, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by JARJOUR, N. N.
Right arrow Articles by ENHORNING, G.

Am. J. Respir. Crit. Care Med., Volume 160, Number 1, July 1999, 336-341

Antigen-induced Airway Inflammation in Atopic Subjects Generates Dysfunction of Pulmonary Surfactant

NIZAR N. JARJOUR and GORAN ENHORNING

Section of Pulmonary and Critical Care Medicine, Department of Medicine, University of Wisconsin School of Medicine and Perinatal Center, Department of Gynecology and Obstetrics, State University of New York at Buffalo, Children's Hospital, Buffalo, New York

If pulmonary surfactant develops a dysfunction, its ability to maintain patency of narrow conducting airways diminishes, which is likely to cause an increased airway resistance. We hypothesized that antigen challenge will cause inflammation in the conducting airways and that this will cause a surfactant dysfunction. Twenty atopic patients underwent bronchoalveolar lavage (BAL) 5 min and 48 h after challenge with antigen in one segment and with saline solution in another. BAL fluid (BALF) cell count, differential, and proteins were determined. Surfactant function was studied with a capillary surfactometer (CS), an instrument specifically designed to evaluate surfactant's ability to maintain patency. Eosinophils increased 80-fold 48 h after antigen challenge and total protein increased from 84 to 241 µg/ml (median values). BALF surfactant lost part of its ability to maintain openness of the capillary, from 68.8% to 14.0% (p < 0.05). Protein concentration negatively correlated with percent openness (r = -0.62, p = 0.005). We conclude that the antigen challenge resulted in an inflammatory reaction that caused pulmonary surfactant to lose some of its ability to maintain airway patency and speculate that surfactant dysfunction is probably an important factor contributing to increased airway obstruction in allergen-induced exacerbation of asthma.




This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
C. G. Irvin and J. H. T. Bates
Physiologic Dysfunction of the Asthmatic Lung: What's Going On Down There, Anyway?
Proceedings of the ATS, May 1, 2009; 6(3): 306 - 311.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
G. Enhorning
Surfactant in Airway Disease
Chest, April 1, 2008; 133(4): 975 - 980.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. L. Sorkness, E. R. Bleecker, W. W. Busse, W. J. Calhoun, M. Castro, K. F. Chung, D. Curran-Everett, S. C. Erzurum, B. M. Gaston, E. Israel, et al.
Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation
J Appl Physiol, February 1, 2008; 104(2): 394 - 403.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. S. Siegle, N. Hansbro, C. Herbert, M. Yang, P. S. Foster, and R. K. Kumar
Airway Hyperreactivity in Exacerbation of Chronic Asthma Is Independent of Eosinophilic Inflammation
Am. J. Respir. Cell Mol. Biol., November 1, 2006; 35(5): 565 - 570.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. D. Hite, M. C. Seeds, D. L. Bowton, B. L. Grier, A. M. Safta, R. Balkrishnan, B. M. Waite, and D. A. Bass
Surfactant phospholipid changes after antigen challenge: a role for phosphatidylglycerol in dysfunction
Am J Physiol Lung Cell Mol Physiol, April 1, 2005; 288(4): L610 - L617.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. D. Hite, M. C. Seeds, A. M. Safta, R. B. Jacinto, J. I. Gyves, D. A. Bass, and B. M. Waite
Lysophospholipid generation and phosphatidylglycerol depletion in phospholipase A2-mediated surfactant dysfunction
Am J Physiol Lung Cell Mol Physiol, April 1, 2005; 288(4): L618 - L624.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. Braun, M. Steinecker, S. Schumacher, and M. Griese
Surfactant function in children with chronic airway inflammation
J Appl Physiol, December 1, 2004; 97(6): 2160 - 2165.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. Zhou, Y. You, A. J. Ryan, and R. K. Mallampalli
Upregulation of surfactant synthesis triggers ABCA1-mediated basolateral phospholipid efflux
J. Lipid Res., September 1, 2004; 45(9): 1758 - 1767.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Baritussio
Lung Surfactant, Asthma, and Allergens: A Story in Evolution
Am. J. Respir. Crit. Care Med., March 1, 2004; 169(5): 550 - 551.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
V. J. Erpenbeck, A. Hagenberg, Y. Dulkys, J. Elsner, R. Balder, H. Krentel, M. Discher, A. Braun, N. Krug, and J. M. Hohlfeld
Natural Porcine Surfactant Augments Airway Inflammation after Allergen Challenge in Patients with Asthma
Am. J. Respir. Crit. Care Med., March 1, 2004; 169(5): 578 - 586.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Haczku, E. N. Atochina, Y. Tomer, Y. Cao, C. Campbell, S. T. Scanlon, S. J. Russo, G. Enhorning, and M. F. Beers
The late asthmatic response is linked with increased surface tension and reduced surfactant protein B in mice
Am J Physiol Lung Cell Mol Physiol, October 1, 2002; 283(4): L755 - L765.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. J. Homer, T. Zheng, G. Chupp, S. He, Z. Zhu, Q. Chen, B. Ma, R. D. Hite, L. I. Gobran, S. A. Rooney, et al.
Pulmonary type II cell hypertrophy and pulmonary lipoproteinosis are features of chronic IL-13 exposure
Am J Physiol Lung Cell Mol Physiol, July 1, 2002; 283(1): L52 - L59.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
A. Haczku, E. N. Atochina, Y. Tomer, H. Chen, S. T. Scanlon, S. Russo, J. Xu, R. A. Panettieri Jr., and M. F. Beers
Aspergillus fumigatus-Induced Allergic Airway Inflammation Alters Surfactant Homeostasis and Lung Function in BALB/c Mice
Am. J. Respir. Cell Mol. Biol., July 1, 2001; 25(1): 45 - 50.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. KRAFT, J. PAK, R. J. MARTIN, D. KAMINSKY, and C. G. IRVIN
Distal Lung Dysfunction at Night in Nocturnal Asthma
Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1551 - 1556.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. M. Wright, P. M. Hockey, G. Enhorning, P. Strong, K. B. M. Reid, S. T. Holgate, R. Djukanovic, and A. D. Postle
Altered airway surfactant phospholipid composition and reduced lung function in asthma
J Appl Physiol, October 1, 2000; 89(4): 1283 - 1292.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Mishra, T. E. Weaver, D. C. Beck, and M. E. Rothenberg
Interleukin-5-mediated Allergic Airway Inflammation Inhibits the Human Surfactant Protein C Promoter in Transgenic Mice
J. Biol. Chem., March 9, 2001; 276(11): 8453 - 8459.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1999 American Thoracic Society
  Membership Renewal